Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases

European Journal of Biochemistry

Volumn 250, Issue 3, 1997, Pages 751-757

  D'Ortho, Marie Pia ^a,b,g   Will, Horst ^c   Atkinson, Susan ^b   Butler, Georgina ^b   Messent, Anthea ^b   Gavrilovic, Jelena ^b   Smith, Bryan ^d   Timpl, Rupert ^e   Zardi, Luciano ^f   Murphy, Gillian ^b  

^a INSERM   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Invitek GmbH   (Germany)

^d UCB PHARMA   (Belgium)

^e MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^f UNIVERSITY OF GENOA   (Italy)

^g FACULTÉ DE MÉDECINE   (France)

Author keywords

Cytokine; Extracellular matrix; Invasion; Tissue inhibitor of matrix metalloproteinase; Wound healing

Indexed keywords

COLLAGENASE; CYTOKINE; GELATINASE A; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CATALYSIS; ENZYME ACTIVE SITE; EXTRACELLULAR MATRIX; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WOUND HEALING;

EID: 6844250127     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.00751.x     Document Type: Article

References (42)

1. Ito, A., Mukaiyama, A., Itoh, Y., Nagase, H., Thorgesen, I. B., Enghild, J. J., Sasguri, Y. & Mori, Y. (1996) Degradation of IL1β by MMP, J. Biol. Chem. 271, 14657-14660.
2. Gearing, A. J. H., Beckett, R. Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M. & Wooley, K. (1994) Processing of TNFα precursor by metalloproteinases, Nature 370, 555-556.
3. Murphy, G. & Reynolds, J. J. (1993) Extracellular matrix degradation, in Connective tissue and its heritable disorders. Molecular, genetic, and medical aspects (Royce, P. M. & Steinmann, B., eds) pp. 287-316, Wiley-Liss, New York.
4. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawas, A., Yamamoto, H. & Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells, Nature 370, 61-65.
5. Takino, T., Sato, H., Shinagawa, A. & Seiki, M. (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library, J. Biol. Chem. 270, 23013-23020.
6. Will, H. & Hinzmann, B. (1995) cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment, Eur. J. Biochem. 231, 602-608.
7. Puente, X. S., Pendas, A. M., Llano, E., Velasco, G. & Lopez-Otin, C. (1996) Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma, Cancer Res. 56, 944-949.
8. Butler, G. S., Will, H., Atkinson, S. J. & Murphy, G. (1997) Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases, Eur. J. Biochem. 244, 653-657.
9. Pei, D. & Weiss, S. J. (1996) Transmembrane-deletion mutants of the membrane type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degradading activity, J. Biol. Chem. 271, 9135-9140.
10. Will, H., Atkinson, S., Butler, G. S., Smith, B. & Murphy, G. (1996) The soluble catalytic domain of membrane-type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and 3, J. Biol. Chem. 271, 17119-17123.
11. Ohuchi, H. Imai, K., Fujii, Y., Sato, H., Seiki, M. & Okada, Y. (1997) MT1-MMP digests interstitial collagens and other extracellular matrix macromolecules, J. Biol. Chem. 272, 2446-2451.
12. Knight, C. G., Willenbrock, F. & Murphy, G. (1992) A novel coumarin-labelled peptide for sensitive continuous asays of the matrix metalloproteinases, FEBS Lett. 296, 263-266.
13. Smilenov, L., Forsberg, E., Zeligman, I., Sparrman, M. & Johansson, S. (1992) Separation of fibronectin from a plasma gelatinase using immobilized metal affinity chromatography, FEBS Lett. 302, 227-230.
14. Siri, A., Knäuper, V., Veinara, N., Caocci, F., Murphy, G. & Zardi, L. (1995) Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases, J. Biol. Chem. 270, 8650-8654.
15. Fox, J. W., Mayer, U., Nischt, R., Aumailley, M., Reinhart, D., Wiedeman, H., Mann, K., Timpl, R., Krieg, T., Engel, J. & Chu, M.-L. (1991) Recombinant nidogen consists of three globular domains and mediate binding of laminin to collagen, EMBO J. 10, 3137-3146.
16. Costell, M., Sasaki, T., Mann, K., Yamada, Y. & Timpl, R. (1996) Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan, FEBS Lett. 396, 127-131.
17. Schulze, B., Sasaki, T., Costell, M., Mann, K. & Timpl, R. (1996) Structural and cell-adhesive properties of three recombinant fragments derived from perlecan domain III, Matrix Biol. 15, 349-357.
18. 14C) acetylated collagen, Anal. Biochem. 99, 340-345.
19. Murphy, G., Willenbrock, F., Ward, R. V., Cockett, M. I., Eaton, D. & Docherty, A. J. P. (1992) The C-terminal domain of 72 kD gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases, Biochem. J. 283, 637-641.
20. Murphy, G., Cockett, M. I., Ward, R. V. & Docherty, A. J. P. (1991) Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan, Biochem. J. 277, 277-279.
21. Knäuper, V., Lòpez-Otin, C., Smith, B., Knight, G. & Murphy, G. (1996) Biochemical characterization of human collagenase-3, J. Biol. Chem. 271, 1544-1550.
22. Murphy, G. & Willenbrock, F. (1995) Tissue inhibitors of matrix metalloendopeptidases, Methods Enzymol. 248, 496-510.
23. Murphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O'Shea, M. & Docherty, A. J. P. (1991) The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity, Biochemistry 30, 8097-8102.
24. Apte, S. S., Olsen, B. R. & Murphy, G. (1995) The gene structure of TIMP-3 and its activities defines the distinct TIMP gene family, J. Biol. Chem. 270, 14313-14318.
25. Okada, Y., Morodomi, T., Enghild, J. J., Suzuki, K., Yasui, A., Makamishi, I., Salvesen, G. & Nagase, H. (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymatic properties, Eur. J. Biochem. 194, 721-730.
26. von Bredow, D. C., Nagle, R. B., Bowden, G. T. & Cress, A. E. (1995) Degradation of fibronectin fibrils by matrilysin and characterization of the degradation products, Exp. Cell Res. 221, 83-91.
27. Woessner, F. & Nagase, H. (1980) An improved assay for proteases and polysaccharidases employing a cartilage proteoglycan substrate entrapped in polyacrylamide particles, Anal. Biochem. 107, 385-392.
28. Fukai, F., Ohtaki, M., Fujii, N., Yajima, H., Ishii, T., Nishizawa, Y., Miyazaki, K. & Katayama, T. (1995) Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases, Biochemistry 34, 11453-11459.
29. Ruoslahti, E. (1989) Proteoglycans in cell regulation, J. Biol. Chem. 264, 13369-13372.
30. Werb, Z., Tremble, P. M., Behrendtsen, P., Crowly, E. & Damsky, C. H. (1989) Signal transduction through the fibronectin receptor induces collagenase and stromelysin expression, J. Cell Biol. 109, 877-889.
31. Homandberg, G. A., Meyers, R. & Xie, D. L. (1992) Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture, J. Biol. Chem. 267, 3597-3604.
32. Clark, R. A. F. (1990) Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin, J. Invest. Dermatol. 94, 128S-134S.
33. Lohr, K. M., Kurth, C. A., Xie, D. L., Seyer, J. M. & Homandberg, G. A. (1990) The aminoterminal 29- and 72-kD fragments of fibronectin mediate selective monocyte recruitment, Blood 76, 2117-2124.
34. Deryugina, E. I. & Bourdon, M. A. (1996) Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin, J. Cell Sci. 109, 643-652.
35. Schwarzbauer, J. E. (1991) Fibronectin: from gene to protein, Curr. Opin. Cell Biol. 3, 786-791.
36. Yamamoto, M., Mohaman, S., Sawaya, R., Fuller, G. N., Seiki, M., Sato, H., Kokaslan, Z. L., Liotta, L. A., Nicolson, G. L. & Rao, J. S. (1996) Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumours in vivo and in vitro, Cancer Res. 56, 384-392.
37. Timpl, R. & Brown, J. C. (1996) Supramolecular assembly of basement membranes, Bioessays 18, 123-132.
38. Costell, M., Mann, K., Yamada, Y. & Timpl, R. (1997) Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides, Eur. J. Biochem. 243, 115-121.
39. Whitelock, J. M., Murdoch, A. D., Iozzo, R. V. & Underwood, P. A. (1996) The degradation of human endothelial cell-derived perlecan and release of bound bFGF by stromelysin, collagenase, plasmin and heparanases, J. Biol. Chem. 271, 10079-10086.
40. Bode, W., Gomis-Ruth, F. X. & Stocker, W. (1993) Astacins, serralysins, sanke venoms and matrix metalloproteinzses exhibit identical zinc-binding environment (HEXXHXXGXXH and Metturn) and topologies and should be grouped into a common family, the 'metzincins', FEBS Lett. 331, 134-140.
41. Noel, A., Santavicca, M., Stoll, I., L'Hoir, C., Staub, A., Murphy, G., Rio, M.-C. & Basset, P. (1995) Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities, J. Biol. Chem. 270, 22866-22872.
42. Knäuper, V. Smith, B., Stanton, H., Hembry, R. & Murphy, G. (1996) Cellular mechanisms for human procollagenase-3 (MMP-13) activation, J. Biol. Chem. 271, 17 124-17 131.